CommoditiesChemicals & PetrochemicalsCommodity Chemicals

Citurgia Biochemicals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 13 filings·Updated 13 Aug 2026
Showing 10 of 13 filings.
13 Aug 20261 filing
ResultFinancial Results

Citurgia Biochemicals reports unaudited Q1 2026 results with loss of 8.20 lakhs

Financial highlights

  • Q1 30.06.2026: Profit before tax negative 8.20 lakhs.
  • Total expenses for the quarter were 8.20 lakhs.
  • Employee benefits expense: 3.00 lakhs; depreciation: 5.15 lakhs; other expenses: 0.05 lakhs.
  • EPS continuing operations: Basic and Diluted 0.000 per share.
Filed 16:32View Source
24 Jul 20261 filing
Company UpdateResignation of Company Secretary / Compliance Officer

Resignation of company secretary

Filed 13:53View Source
30 Jun 20261 filing
Insider Trading / SASTClosure of Trading Window

Citurgia Biochemicals Limited - Closure of Trading Window for declaration of Un-audited Financial Results for the quarter ending June 30, 2026; window closed from 01 July 2026 until 2 calendar days after the Board meeting date.

Citurgia Biochemicals Limited - Closure of Trading Window for declaration of Un-audited Financial Results for the quarter ending June 30, 2026; window closed from 01 July 2026 until 2 calendar days after the Board meeting date.

Filed 15:21View Source
29 May 20261 filing
Company UpdateGeneral

Appointment of Chief Financial Officer (CFO)

Filed 12:42View Source
21 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026

Filed 13:13View Source
31 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

CLOSURE OF TRADING WINDOW FOR THE DECLARATION OF AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDING ON 31.03.2026

Filed 11:41View Source
5 Feb 20261 filing
Board Meeting

Citurgia Biochemicals Ltd - 506373 - Board Meeting Intimation for Consider And Approve Unaudited Financial Result For The Quarter Ended On 31.12.2025

🗓️ Meeting Details

  • Board meeting scheduled for 14 February 2026, Saturday.

📍 Key Agenda Items

  • Approval of unaudited standalone financial results for quarter ended 31 December 2025.
Filed 16:12View Source
2 Jan 20261 filing
Insider Trading / SASTClosure of Trading Window

CLOSURE OF TRADING WINDOW

Filed 12:02View Source
23 Dec 20251 filing
Company UpdateAppointment of Company Secretary / Compliance Officer

Appointment of Company Secretary and Compliance Officer

Filed 13:29View Source
6 Oct 20251 filing
OthersReg. 34 (1) Annual Report

Annual Report 2024-25

Filed 16:40View Source
Showing 10 of 13 filings